Scheen, A., Paquot, N., & Lefèbvre, P. (May 2023). L’hypoglycémie réactionnelle : un trouble fonctionnel fréquemment évoqué, mais surestimé en pratique clinique. Revue Médicale de Liège, 78 (5-6), 363-368. |
Scheen, A., & Lefèbvre, P. (February 2023). Glucagon, from past to present: a century of intensive research and controversies. The Lancet Diabetes and Endocrinology, 11 (2), 129-138. doi:10.1016/S2213-8587(22)00349-7 |
SCHEEN, A., & Lefèbvre, P. (2021). L'épopée des insulines des années 1930 aux années 1980. Médecine des Maladies Métaboliques. doi:10.1016/S1957-2557(21)00177-2 |
Scheen, A., Lefèbvre, P., & Paquot, N. (2018). La metformine revisitee : moins de restrictions et davantage d'indications. Revue Médicale de Liège, 73 (11), 544-549. |
Scheen, A., Paquot, N., & Lefèbvre, P. (2017). Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes. Expert Opinion on Investigational Drugs, 26 (12), 1373-1389. doi:10.1080/13543784.2017.1395020 |
SCHEEN, A., PAQUOT, N., & LEFEBVRE, P. (September 2016). La vignette diagnostique de l’étudiant Mise au point d’une suspicion de malaise hypoglycémique chez une personne adulte non diabétique. Revue Médicale de Liège, 71 (09), 407-413. |
LEFEBVRE, P., Paquot, N., & Scheen, A. (2015). Inhibiting or Antagonizing Glucagon: A Progress in Diabetes Care ? Diabetes, Obesity and Metabolism. doi:10.1111/dom.12480 |
Scheen, A., Lefebvre, P., & Kulbertus, H. (2010). Prevention cardio-vasculaire: la "polypill", une solution pour vaincre l'inertie clinique et le manque d'observance? Revue Médicale de Liège, 65 (5-6), 267-72. |
Lefebvre, P., & Scheen, A. (2009). Les cas cliniques, une vision panachee de la medecine: de la simple anecdote a l'enseignement pratique. Revue Médicale de Liège, 64 (7-8), 357. |
Scheen, A., & Lefebvre, P. (2009). Insuline glargine et cancer: une tempete dans un verre d'eau? Revue Médicale de Liège, 64 (9), 440-5. |
Radermecker, R., Philips, J.-C., Jandrain, B., Paquot, N., Lefebvre, P., & Scheen, A. (2008). Le cerveau, un organe gluco-dependant. Effets deleteres de l'hypoglycemie et de l'hyperglycemie. Revue Médicale de Liège, 63 (5-6), 280-6. |
Scheen, A., Paquot, N., & Lefebvre, P. (2008). L'etude clinique du mois. United Kingdom Prospective Diabetes Study: 10 ans plus tard. Revue Médicale de Liège, 63 (10), 624-9. |
Fysekidis, M., Hadjadj, S., Roussel, R., Bellili, N., Madani, S., Fumeron, F., Leblanc, H., Gautier, J., Weekers, L., Bauduceau, B., Charpentier, G., Virally, M., Alhenc-Gelas, F., Lefèbvre, P., & Marre, M. (September 2007). ACE I/D polymorphism predicts end stage renal disease and or mortality in type I diabetic patients except for those with already advanced nephropathy: the follow up of the Genesis/Genediab Studies. Diabetologia, 50 (Suppl. 1), 157-S158. |
Paquot, N., Philips, J. C., Radermecker, R., & Lefèbvre, P. (2007). Actualites therapeutiques en diabetologie. Revue Médicale de Liège, 62 (5-6, May-Jun), 317-23. |
Scheen, A., Luyckx, F., & Lefebvre, P. (2006). Comment j'explore...le syndrome metabolique par sa nouvelle definition dite de "consensus". Revue Médicale de Liège, 61 (1), 48-52. |
Scheen, A., & Lefebvre, P. (2005). Le diabete sucre: epilogue. Revue Médicale de Liège, 60 (5-6), 628-31. |
Scheen, A., & Lefebvre, P. (2005). L'etude Proactive: prevention secondaire des accidents cardio-vasculaires par la pioglitazone chez le patient diabetique de type 2. Revue Médicale de Liège, 60 (11), 896-901. |
Krzentowski, G., Zhang, L., Albert, A., & Lefèbvre, P. (October 2004). Un autre regard sur les implications de l'etude DCCT. Annales d'Endocrinologie, 65 (5), 429-435. doi:10.1016/s0003-4266(04)95947-1 |
Letiexhe, M., Desaive, C., Lefebvre, P., & Scheen, A. (2004). Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients. International Journal of Obesity, 28 (6), 821-3. doi:10.1038/sj.ijo.0802632 |
Scheen, A., & Lefebvre, P. (2004). L'hypoglycemie reactive: un phenomene critique mysterieux, insidieux, mais non dangereux. Revue Médicale de Liège, 59 (4), 237-42. |
Zhang, L., Krzentowski, G., Albert, A., & Lefèbvre, P. (July 2003). Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control. Diabetic Medicine: A Journal of the British Diabetic Association, 20 (7), 580-585. doi:10.1046/j.1464-5491.2003.00986.x |
Gaspard, U., Scheen, A., Endrikat, J., Buicu, C., Lefebvre, P., Gerlinger, C., & Heithecker, R. (2003). A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism. Contraception, 67 (6), 423-9. doi:10.1016/S0010-7824(02)00537-1 |
Scheen, A., Lefebvre, P., & Kulbertus, H. (2003). Comment je previens ... les maladies cardio-vasculaires par une approche pharmacologique combinee: y a-t-il place pour une polypill"?". Revue Médicale de Liège, 58 (9), 527-33. |
Ludicke, F., Gaspard, U., Demeyer, F., Scheen, A., & Lefebvre, P. (2002). Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception, 66 (6), 411-5. doi:10.1016/S0010-7824(02)00415-8 |
Paquot, N., Scheen, A., Dirlewanger, M., Lefebvre, P., & Tappy, L. (2002). Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obesity Research, 10 (3), 129-34. doi:10.1038/oby.2002.21 |
Scheen, A., & Lefebvre, P. (2002). Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents. Diabetes Care, 25 (1), 247-8. doi:10.2337/diacare.25.1.247 |
Scheen, A., Paquot, N., Jandrain, B., & Lefebvre, P. (2002). L'hyperglycemie post-prandiale. I. Physiopathologie, consequences cliniques et approaches dietetiques. Revue Médicale de Liège, 57 (3), 138-41. |
Geenen, V., Kecha, O., Lefebvre, P., & Greiner, D. L. (2001). The role of the thymus in T cell self-tolerance of neuroendocrine principles and in development of neuroendocrine autoimmunity. Journal of Neuroimmunology, 118, 166. |
Lefebvre, P., & Scheen, A. (2001). Obesity: causes and new treatments. Experimental and Clinical Endocrinology and Diabetes, 109 Suppl 2, 215-24. doi:10.1055/s-2001-18583 |
Estrella, F., Scheen, A., MARCHAND, M., Weekers, L., & Lefèbvre, P. (2000). Relationship between incipiens nephropathy and cardiac autonomic neuropathy in type 1 diabetes. Diabetes, 49 (sup. 1), 379-A380. |
Kecha, O., Martens, H., Brilot, F., Renard, C., Lefebvre, P., Greiner, D. L., & Geenen, V. (2000). Thymic insulin-related genes: role in T-lymphocyte development and self-tolerance of the insulin family. Pflügers Archiv: European Journal of Physiology, 440, 224. |
Luyckx, F., Lefebvre, P., & Scheen, A. (2000). Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes and Metabolism, 26 (2), 98-106. |
Ordonez, A. J., Rodriguez-Castro, C., Zamora, J., Rubio, J. L., Scheen, A., Lefebvre, P., & Castillo, M. (2000). Developpement et utilisation d'un systeme de telemedecine pour le suivi medical des patients diabetiques. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 179-94. |
Paquot, N., Castillo, M. J., Lefebvre, P., & Scheen, A. (2000). No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. Journal of Clinical Endocrinology and Metabolism, 85 (3), 1316-9. doi:10.1210/jc.85.3.1316 |
Paquot, N., Scheen, A., & Lefebvre, P. (2000). Le controle glycemique chez le patient diabetique. Recommandations apres les etudes DCCT et UKPDI. Revue Médicale de Liège, 55 (5), 372-5. |
Paquot, N., Schneiter, P., Scheen, A., Lefebvre, P., & Tappy, L. (2000). Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects. International Journal of Obesity, 24 (10), 1297-302. doi:10.1038/sj.ijo.0801386 |
SCHEEN, A., Estrella, F., PHILIPS, J.-C., MARCHAND, M., & LEFEBVRE, P. (2000). Autonomic dysfunction evidenced by a squatting test in type 1 diabetic patients: effect of disease duration. Diabetologia, 43 (supp), 279. |
Scheen, A., & Lefebvre, P. (2000). Antiobesity pharmacotherapy in the management of type 2 diabetes. Diabetes/Metabolism Research and Reviews, 16 (2), 114-24. doi:10.1002/(SICI)1520-7560(200003/04)16:2<114::AID-DMRR97>3.0.CO;2-O |
Scheen, A., Rorive, M., Estrella, F., Weekers, L., & Lefebvre, P. (2000). Recommandations a propos du traitement de l'hypertension arterielle chez le patient diabetique. Revue Médicale de Liège, 55 (5), 376-82. |
Zhang, L., Krzentowski, G., Albert, A., & Lefèbvre, P. (2000). Risk of Developiment and progression of retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control. Diabete (Le). |
Gaspard, U., Wery, O., Scheen, A., Jaminet, C., & Lefebvre, P. (1999). Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric: the Journal of the International Menopause Society, 2 (2), 93-100. doi:10.3109/13697139909025572 |
Geronooz, I., Scheen, A., & Lefebvre, P. (1999). Le diabete gestationnel: physiopathologie et signification pronostique pour la mere. Revue Médicale de Liège, 54 (5), 434-9. |
Kecha, O., Winkler, R., Martens, H., Collette, J., Lefebvre, P., Greiner, D. L., & Geenen, V. (1999). Thymic insulin-related polypeptides in diabetes-prone Bio-Breeding rats. Diabetologia, 42 (Suppl. 1), 29. |
Lefebvre, P., & Scheen, A. (1999). State of current therapy and patient care in Europe. International Journal of Clinical Practice. Supplement, 107, 6-10. |
Lefebvre, P., & Scheen, A. (1999). Glucose metabolism and the postprandial state. European Journal of Clinical Investigation, 29 Suppl 2, 1-6. doi:10.1046/j.1365-2362.1999.00003.x |
Luyckx, F., Scheen, A., Desaive, C., Thiry, A., & Lefebvre, P. (1999). Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity. Journal of Clinical Endocrinology and Metabolism, 84 (11), 4293. doi:10.1210/jcem.84.11.6171-4 |
Luyckx, F., Scheen, A., & Lefebvre, P. (1999). Non-alcoholic steatohepatitis. The Lancet, 354 (9186), 1298-9. doi:10.1016/S0140-6736(05)76068-2 |
Luyckx, F., Scheen, A., & Lefebvre, P. (1999). L'obesite feminine: souci esthetique ou probleme medical? Revue Médicale de Liège, 54 (4), 262-7. |
Luyckx, F., Scheen, A., Letiexhe, M., Desaive, C., Gielen, J.-L., & Lefebvre, P. (1999). Comment je traite ... une obesite severe et ses anomalies metaboliques par une gastroplastie. Revue Médicale de Liège, 54 (3), 138-42. |
Paolisso, G., Tagliamonte, M. R., Rizzo, M. R., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1999). Le vieillissement s'accompagne-t-il d'une diminution de la sensibilite a l'insuline? Roles de l'IGF1 et de la dehydroepiandrosterone. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 63-74. |
Scheen, A., & Lefebvre, P. (1999). Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. Diabetes Care, 22 (9), 1568-77. doi:10.2337/diacare.22.9.1568 |
Scheen, A., & Lefebvre, P. (1999). Pharmacological treatment of obesity: present status. International Journal of Obesity, 23 Suppl 1, 47-53. doi:10.1038/sj.ijo.0800795 |
Scheen, A., & Lefebvre, P. (1999). L'homeopathie est-elle superieure au placebo? Controverse a propos d'une meta-analyse des etudes controlees. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 154 (7-9), 295-304; discussion 304-7. |
Scheen, A., Letiexhe, M., & Lefebvre, P. (1999). Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme. Diabetes and Metabolism, 25 (2), 157-62. |
Scheen, A., Luyckx, F., Desaive, C., & Lefebvre, P. (1999). Severe/extreme obesity: a medical disease requiring a surgical treatment? Acta Clinica Belgica, 54 (3), 154-61. doi:10.1080/17843286.1999.11754222 |
Scheen, A., Paquot, N., & Lefebvre, P. (1999). Glucotoxicite et lipotoxicite, deux complices impliques dans le cercle vicieux du diabete de type 2. Revue Médicale de Liège, 54 (6), 535-8. |
Scheen, A., Paquot, N., Letiexhe, M., & Lefebvre, P. (1999). Thiazolidinediones. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 213-29. |
Paquot, N., Roulin, D., Schneiter, P., Ruiz, J., Lefèbvre, P., Pahud, P., & Tappy, L. (December 1998). Effects of Regular Insulin or Insulin Lispro on Glucose Metabolism after an Oral Glucose Load in Patients with Type 2 Diabetes Mellitus. Diabetes and Metabolism, 24 (6), 523-8. |
Saint-Remy, A., Scheen, A., LEFEBVRE, P., & Rorive, G. (04 September 1998). Adverse effect of hyperinsulinemia on cardiovascular risk profile in middle-aged belgian population [Paper presentation]. Joint Scientific Meeting of the Dutch and Belgian Societies of hypertension, Mölndorf Hotel (Mölndorf), Luxembourg. |
Lefebvre, P., & Scheen, A. (1998). The postprandial state and risk of cardiovascular disease. Diabetic Medicine: A Journal of the British Diabetic Association, 15 Suppl 4, 63-8. doi:10.1002/(SICI)1096-9136(1998120)15:4+ |
Luyckx, F., Desaive, C., Thiry, A., Dewe, W., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1998). Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. International Journal of Obesity, 22 (3), 222-6. doi:10.1038/sj.ijo.0800571 |
Luyckx, F., Scheen, A., Desaive, C., Dewe, W., Gielen, J.-L., & Lefebvre, P. (1998). Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes and Metabolism, 24 (4), 355-61. |
Luyckx, F., Scheen, A., Proenza, A. M., Strosberg, A. D., Lefebvre, P., & Gielen, J.-L. (1998). Influence of the A-->G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects. International Journal of Obesity, 22 (12), 1244-5. doi:10.1038/sj.ijo.0800775 |
Philips, J.-C., Scheen, A., Firre, E., Robin, M., Cambier, P., & Lefebvre, P. (1998). Le cas clinique du mois. Une nephropathie galopante chez un patient diabetique de type 2. Revue Médicale de Liège, 53 (4), 171-4. |
Radermecker, R., Scheen, A., Letiexhe, M., Lefebvre, P., & De Mol, P. (1998). Implications virales dans l'etiopathogenie du diabete de type 1: donnees actuelles. Revue Médicale de Liège, 53 (10), 597-602. |
Saint-Remy, A., Scheen, A., Jeanjean, M., LEFEBVRE, P., & Rorive, G. (1998). Adverse effect of hyperinsulinemia on cardiovascular risk profile in middle-aged belgian population. Acta Cardiologica, 53 (5), 299. |
Scheen, A., & Lefebvre, P. (1998). Pharmaco-economie du diabete de type 2. Revue Médicale de Liège, 53 (5), 285-9. |
Scheen, A., & Lefebvre, P. (1998). Oral antidiabetic agents. A guide to selection. Drugs, 55 (2), 225-36. doi:10.2165/00003495-199855020-00004 |
Scheen, A., & Lefebvre, P. (1998). Info-congres. Les lecons de la "United Kingdom Prospective Diabetes Study". Revue Médicale de Liège, 53 (9), 576-8. |
Scheen, A., Paquot, N., Triches, K., Luyckx, F., Letiexhe, M., & Lefebvre, P. (1998). Traitement ultime du diabete de type 2: insulinotherapie intensive ou chirurgie bariatrique? Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 81-97. |
Scheen, A., Triches, K., Luyckx, F., Letiexhe, M., & Lefebvre, P. (1998). Pharma clinics. Comment je traite ... un patient diabetique avec obesite severe. Revue Médicale de Liège, 53 (7), 386-9. |
Weekers, L., Scheen, A., & Lefebvre, P. (1998). Comment j'explore ... la nephropathie diabetique. Premiere partie: micro- et macro-albuminurie. Revue Médicale de Liège, 53 (8), 494-8. |
Saint-Remy, A., Scheen, A., LEFEBVRE, P., JEANJEAN, M., & Rorive, G. (11 December 1997). Are fasting and postload insulin good markers of cardiovascular risk factors? [Paper presentation]. Conférence Inter hospitalière de Diabétologie / Endocrinologie, Liège, Belgium. |
Leclercq, D., & Lefèbvre, P. (July 1997). Distance learning and education for diabetes care. Journal of the Diabetic Association of India, 37 (3), 71-76. |
Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75 |
Bozet, M.-C., Gerard, P., Scheen, A., Lefebvre, P., & Castillo, M. J. (1997). Determination rapide par immunodosage de l'hemoglobine glyquee sur sang capillaire comparee a une methode d'affinite pour le boronate et capture d'ions sur sang veineux. Annales de Biologie Clinique, 55 (2), 139-44. |
Geenen, V., Kecha, O., Achour, I., Goxe, B., Winkler, R., & Lefèbvre, P. (1997). Molecular dissection of the insulin-like growth factor axis in the human thymus. Diabetologia, 40, 23. |
Geenen, V., & Lefebvre, P. (1997). Expression of insulin-related peptides in the human thymus. International Diabetes Monitor, 9, 13-14. |
Hodzic, D., Delacroix, L., Willemsen, P., Bensbaho, K., Collette, J., Broux, R., Lefebvre, P., Legros, J.-J., Grooteclaes, M., & Winkler, R. (1997). Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma. Hormone and Metabolic Research, 29 (11), 549-55. doi:10.1055/s-2007-979099 |
Kecha, O., Achour, I., Martens, H., Winkler, R., Lefebvre, P., & Geenen, V. (1997). Characterization of the insulin-like growth (IGF) axis in the human thymus. In The Endocrine Society, Proceedings of the 77th Annual Meeting of the Endocrine Society (pp. 150 (P3-259). |
Letiexhe, M., Scheen, A., & Lefebvre, P. (1997). Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa. Eating and Weight Disorders, 2 (2), 79-86. |
Luyckx, F., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1997). Le recepteur beta 3-adrenergique: un role dans la predisposition genetique a l'obesite et au diabete? Revue Médicale de Liège, 52 (11), 703-8. |
Luyckx, F., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1997). Comment j'explore ... le syndrome d'insulinoresistance grace a ses marqueurs biologiques. Revue Médicale de Liège, 52 (10), 686-91. |
Overkamp, D., Gautier, J. F., Renn, W., Pickert, A., Scheen, A., Schmulling, R. M., Eggstein, M., & Lefebvre, P. (1997). Glucose turnover in humans in the basal state and after intravenous glucose: a comparison of two models. American Journal of Physiology, 273 (2 Pt 1), 284-96. doi:10.1152/ajpendo.1997.273.2.e284 |
Piéron, M., Scheen, A., Corhay, J.-L., Radermecker, M., & Lefebvre, P. (1997). Reactivite bronchique chez les patients diabetiques. Revue des Maladies Respiratoires, 14 (5), 379-85. |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1996). The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level. Journal of Clinical Endocrinology and Metabolism, 81 (5), 1975-8. doi:10.1210/jc.81.5.1975 |
Castillo, M. J., Scheen, A., Paolisso, G., & Lefebvre, P. (1996). Exhaustion of blood glucose response and enhancement of insulin response after repeated glucagon injections in type-2 diabetes: potentiation by progressive hyperglycemia. Annales d'Endocrinologie, 57 (5), 395-402. |
Gautier, J. F., Pirnay, F., Lacroix, M., Mosora, F., Scheen, A., Cathelineau, G., & Lefebvre, P. (1996). Changes in breath 13CO2/12CO2 during exercise of different intensities. Journal of Applied Physiology, 81 (3), 1096-102. doi:10.1152/jappl.1996.81.3.1096 |
Geenen, V., Achour, I., Kecha, O., Greiner, D. L., Rossini, A. A., & Lefebvre, P. (1996). Thymic insulin-like growth factors (IGFs) in man and in an animal model of autoimmune IDDM. Diabetologia, 39, 15. |
Scheen, A., Castillo, M. J., & Lefebvre, P. (1996). Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement. Diabetes and Metabolism, 22 (6), 455-8. |
Scheen, A., Castillo, M. J., & Lefebvre, P. (1996). Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes and Metabolism, 22 (6), 397-406. |
Scheen, A., & Lefebvre, P. (1996). Le diabete non insulinodependant: de la physiopathologie au traitement. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 151 (7-9), 395-402; discussion 402-5. |
Scheen, A., & Lefebvre, P. (1996). Insulin action in man. Diabetes and Metabolism, 22 (2), 105-10. |
Bozet, M.-C., Scheen, A., Gerard, P., Castillo, M. J., & Lefebvre, P. (1995). Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabète et Métabolisme, 21 (5), 353-9. |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1995). Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 80 (2), 393-9. doi:10.1210/jcem.80.2.7852495 |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1995). Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabète et Métabolisme, 21 (1), 3-25. |
Geenen, V., Goxe, B., Martens, H., Vandersmissen, E., Vanneste, Y., Achour, I., Kecha, O., & Lefebvre, P. (1995). Cryptocrine Signaling in the Thymus Network and T Cell Education to Neuroendocrine Self-Antigens. Journal of Molecular Medicine, 73 (9), 449-55. doi:10.1007/BF00202263 |
Geenen, V., Vandersmissen, E., Martens, H., Goxe, B., Kecha, O., Legros, J.-J., Lefebvre, P., Benhida, A., Rentier-Delrue, F., & Martial, J. (1995). Cellular and molecular aspects of thymic T-cell education to neurohypophysial peptides. In S. Yoshida, T. Saito (Ed.), ... K. Kurokawa (Ed.), Neurohypophysis - Recent Progress of Vasopressin and Oxytocin Research (pp. 309-319). New York, United States: Elsevier Science. |
Kaiser, M.-J., Achour, I., Kecha, O., Goxe, B., De Groote, D., Lefebvre, P., & Geenen, V. (1995). Vieillissement, défenses immunitaires at axe somatotrope-facteurs de croissance apparentés à l'insuline. Médecine et Hygiène, 53, 1608-1610. |
Lefebvre, P., & Scheen, A. (1995). Improving the action of insulin. Clinical and Investigative Medicine, 18 (4), 340-7. |
Letiexhe, M., Scheen, A., Gerard, P., Desaive, C., & Lefebvre, P. (1995). Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. Journal of Clinical Endocrinology and Metabolism, 80 (2), 364-9. doi:10.1210/jcem.80.2.7852491 |
Paolisso, G., Scheen, A., & Lefebvre, P. (1995). Glucose handling, diabetes and ageing. Hormone Research, 43 (1-3), 52-7. doi:10.1159/000184237 |
Pirnay, F., Scheen, A., Gautier, J. F., Lacroix, M., Mosora, F., & Lefebvre, P. (1995). Exogenous glucose oxidation during exercise in relation to the power output. International Journal of Sports Medicine, 16 (7), 456-60. doi:10.1055/s-2007-973037 |
Scheen, A., & Lefebvre, P. (1995). Antihyperglycaemic agents. Drug interactions of clinical importance. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 12 (1), 32-45. doi:10.2165/00002018-199512010-00003 |
Scheen, A., Letiexhe, M., & Lefebvre, P. (1995). Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance. Diabetic Medicine: A Journal of the British Diabetic Association, 12 (11), 985-9. doi:10.1111/j.1464-5491.1995.tb00410.x |
Scheen, A., Paquot, N., Letiexhe, M., Castillo, M. J., & Lefebvre, P. (1995). Comment explorer la sensibilite a l'insuline chez l'homme? Annales d'Endocrinologie, 56 (5), 523-30. |
Scheen, A., Paquot, N., Letiexhe, M., Paolisso, G., Castillo, M. J., & Lefebvre, P. (1995). Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies. International Journal of Obesity, 19 Suppl 3, 14-20. |
Castillo, M. J., Scheen, A., Jandrain, B., & Lefebvre, P. (1994). Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. International Journal of Obesity, 18 (1), 47-53. |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1994). Metabolic clearance rate of insulin in type 2 diabetic patients treated with combined insulin and sulfonylurea therapy. Revista Espanola de Fisiologia, 50 (1), 27-34. |
Duysinx, B., Scheen, A., Gerard, P., Letiexhe, M., Paquot, N., & Lefebvre, P. (1994). Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility. Diabète et Métabolisme, 20 (4), 425-32. |
Gautier, J. F., Pirnay, F., Jandrain, B., Lacroix, M., Mosora, F., Scheen, A., Cathelineau, G., & Lefebvre, P. (1994). Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade. European Journal of Applied Physiology and Occupational Physiology, 68 (5), 406-12. doi:10.1007/BF00843737 |
Geenen, V., Martens, H., Kecha, O., Achour, I., Lefebvre, P., Franchimont, P., & Goxe, B. (1994). Les choix stratégiques actuels dans la prévention du processus diabétogène auto-immun. Médecine et Hygiène, 52, 1655-1658. |
Geenen, V., Martens, H., Vandersmissen, E., Kecha, O., Benhida, A., Cormann-Goffin, N., Lefebvre, P., & Franchimont, P. (1994). Thymic neuroendocrine self peptides and T-cell selection. In E. Heinen, M.-P. Defresne, J. Boniver, ... V. Geenen (Eds.), In Vivo Immunology - Regulatory Processes during Lymphopoiesis and Immunopoiesis. New York, United States: Plenum. doi:10.1007/978-1-4615-2492-2_4 |
Lefebvre, P., Paolisso, G., & Scheen, A. (1994). Magnesium et metabolisme glucidique. Thérapie, 49 (1), 1-7. |
Lefebvre, P., & Scheen, A. (1994). The use of acarbose in the prevention and treatment of hypoglycaemia. European Journal of Clinical Investigation, 24 Suppl 3, 40-4. doi:10.1111/j.1365-2362.1994.tb02255.x |
Letiexhe, M., Scheen, A., Gerard, P., Desaive, C., & Lefebvre, P. (1994). Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. International Journal of Obesity, 18 (5), 295-300. |
Marfella, R., Salvatore, T., Giugliano, D., Di Maro, G., Giunta, R., Torella, R., Juchmes, J., Scheen, A., & Lefebvre, P. (1994). Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM. Diabetes Care, 17 (2), 149-51. doi:10.2337/diacare.17.2.149 |
Paolisso, G., Scheen, A., Cozzolino, D., Di Maro, G., Varricchio, M., D'Onofrio, F., & Lefebvre, P. (1994). Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. Journal of Clinical Endocrinology and Metabolism, 78 (6), 1510-4. doi:10.1210/jcem.78.6.8200955 |
Saint-Remy, A., Beck, D., Lefèbvre, P., Jeanjean, M., & Rorive, G. (1994). Epidemiology of insulin resistance and hypertension in adults - MONICA BELLUX- preliminary results. Cardiovascular Disease Epidemiology Newsletter, Amercian Heart Association, 49, 50-51. |
Scheen, A., de Magalhaes, A. C., Salvatore, T., & Lefebvre, P. (1994). Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man. European Journal of Clinical Investigation, 24 Suppl 3, 50-4. doi:10.1111/j.1365-2362.1994.tb02257.x |
Scheen, A., Desaive, C., & Lefebvre, P. (1994). Therapy for obesity--today and tomorrow. Bailliere's Clinical Endocrinology and Metabolism, 8 (3), 705-27. doi:10.1016/S0950-351X(05)80292-7 |
Beck, D., Saint-Remy, A., LEFEBVRE, P., Jeanjean, M., & Rorive, G. (1993). Insulinemia and glycemia in free antihypertensive medicated adults - MONICA BELLUX. Acta Clinica Belgica, 6, 423. |
Gautier, J. F., Pirnay, F., Jandrain, B., Lacroix, M., Mosora, F., Scheen, A., & Lefebvre, P. (1993). Endogenous substrate oxidation during exercise and variations in breath 13CO2/12CO2. Journal of Applied Physiology, 74 (1), 133-8. doi:10.1152/jappl.1993.74.1.133 |
Geenen, V., Achour, I., Martens, H., Lefebvre, P., & Franchimont, P. (1993). Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. In The Endocrine Society, Proceedings of the 75th Annual Meeting of the Endocrine Society (pp. 879). |
Geenen, V., Achour, I., Robert, F., Vandersmissen, E., Sodoyez, J.-C., Defresne, M.-P., Boniver, J., Lefebvre, P., & Franchimont, P. (1993). Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus, 21 (2), 115-127. |
Letiexhe, M., Scheen, A., Gerard, P., Bastens, B. H., Pirotte, J., Belaiche, J., & Lefebvre, P. (1993). Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. Journal of Clinical Endocrinology and Metabolism, 77 (5), 1263-8. doi:10.1210/jcem.77.5.8077319 |
LETIEXHE, M., SCHEEN, A., PAQUOT, N., DESAIVE, C., & LEFEBVRE, P. (1993). Effects of moderate vs marked weight loss on insulin sensitivity and androgenic markers in obese women. In H. Ditschuneit, F. A. Gries, H. Hauner, V. Schusdziarra, ... J. G. Wechsler (Eds.), Obesity in Europe (pp. 469-473). John Libbey & Company Ltd. |
Scheen, A., Castillo, M. J., & Lefebvre, P. (1993). Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes. Acta Clinica Belgica, 48 (4), 259-68. doi:10.1080/17843286.1993.11718317 |
Scheen, A., Jandrain, B., Humblet, D., Jaminet, C. B., Gaspard, U., & Lefebvre, P. (1993). Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism. Fertility and Sterility, 59 (4), 797-802. doi:10.1016/s0015-0282(16)55862-2 |
Scheen, A., & Lefebvre, P. (1993). Pharmacological treatment of the obese diabetic patient. Diabète et Métabolisme, 19 (6), 547-59. |
Lefebvre, P., & Scheen, A. (1992). Management of non-insulin-dependent diabetes mellitus. Drugs, 44 Suppl 3, 29-38. doi:10.2165/00003495-199200443-00005 |
Moutschen, M., Scheen, A., & Lefebvre, P. (1992). Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabète et Métabolisme, 18 (3), 187-201. |
Paolisso, G., Sgambato, S., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1992). Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery. European Journal of Medicine, 1 (5), 261-7. |
Pochet, T. F. J., Gérard, P., Fossion, A., Pirotton, M., Scheen, A., Lefebvre, P., & Juchmes, J. (1992). Squatting to standing: an unusual but powerful postural manoeuvre to investigate human arterial blood pressure regulation. Archives of Physiology and Biochemistry, 100 (5), 31-51. doi:10.3109/13813459209000732 |
Scheen, A., & Lefebvre, P. (1992). Assessment of insulin resistance in vivo: application to the study of type 2 diabetes. Hormone Research, 38 (1-2), 19-27. doi:10.1159/000182467 |
Geenen, V., Martens, H., Robert Françoise, Legros, J.-J., Degiovanni, G., Defresne, M.-P., Boniver, J., Martial, J., Lefèbvre, P., & Franchimont, P. (1991). Thymic cryptocrine signaling and the immune recognition of self neuroendocrine functions. Progress in Neuroendocrinimmunology, 4, 135-142. |
Geenen, V., Robert, F., Legros, J.-J., Defresne, M.-P., Boniver, J., Martial, J., Lefebvre, P., & Franchimont, P. (1991). Neuroendocrine-Immunology: from systemic interactions to the immune tolerance of self neuroendocrine functions. Acta Clinica Belgica, 46, 135-141. doi:10.1080/17843286.1991.11718156 |
Lilet, H., Krzentowski, G., Bodson, A., Scheen, A., & Lefebvre, P. (1991). Absence de benefice de l'administration intermittente de l'insuline lors d'un traitement par pompe a perfusion sous-cutanee chez le diabetique de type-1. Diabète et Métabolisme, 17 (3), 363-72. |
Paolisso, G., Scheen, A., Giugliano, D., Sgambato, S., Albert, A., Varricchio, M., D'Onofrio, F., & Lefebvre, P. (1991). Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. Journal of Clinical Endocrinology and Metabolism, 72 (3), 607-15. doi:10.1210/jcem-72-3-607 |
Scheen, A., Paolisso, G., Salvatore, T., & Lefebvre, P. (1991). Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine. Diabetes Care, 14 (4), 325-32. doi:10.2337/diacare.14.4.325 |
Jandrain, B., Humblet, D., Jaminet, C. B., Scheen, A., Gaspard, U., & Lefebvre, P. (1990). Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial. American Journal of Obstetrics and Gynecology, 163 (1 Pt 2), 378-81. doi:10.1016/0002-9378(90)90586-V |
Jandrain, B., Lefèbvre, P., Pirnay, F., & Scheen, A. (1990). Alimentation avant, pendant et après l'exercice physique chez le sujet normal et diabétique. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 159-70. |
Paolisso, G., Buonocore, S., Gentile, S., Sgambato, S., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1990). Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age. Diabetologia, 33 (5), 272-7. doi:10.1007/BF00403320 |
Paolisso, G., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1990). Magnesium and glucose homeostasis. Diabetologia, 33 (9), 511-4. doi:10.1007/BF00404136 |
Castillo, M. J., Scheen, A., Gualda, P., & Lefebvre, P. (1989). Papel de la insulina y hormonas de contra-regulacion en las alteraciones metabolicas por deprivacion de insulina en pacientes diabeticos. Revista Espanola de Fisiologia, 45 (1), 53-9. |
Jandrain, B., Pirnay, F., Lacroix, M., Mosora, F., Scheen, A., & Lefebvre, P. (1989). Effect of osmolality on availability of glucose ingested during prolonged exercise in humans. Journal of Applied Physiology, 67 (1), 76-82. doi:10.1152/jappl.1989.67.1.76 |
Paolisso, G., Scheen, A., Albert, A., & Lefebvre, P. (1989). Effects of pulsatile delivery of insulin and glucagon in humans. American Journal of Physiology, 257 (5 Pt 1), 686-96. |
Scheen, A., Gillet, J., Rosenthaler, J., Guiot, J., Henrivaux, P., Jandrain, B., & Lefebvre, P. (1989). Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients. Diabetologia, 32 (11), 801-9. doi:10.1007/BF00264911 |
Scheen, A., & Lefebvre, P. (1989). Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas. Diabetes Research and Clinical Practice, 6 (4), 33-42; discussion S42-3. doi:10.1016/0168-8227(89)90076-4 |
Giugliano, D., Torella, R., Scheen, A., Lefebvre, P., & D'Onofrio, F. (1988). Prostaglandines, secretion d'insuline et diabete sucre. Diabète et Métabolisme, 14 (6), 721-7. |
Jandrain, B., Pirnay, F., Scheen, A., & Lefebvre, P. (1988). Adaptations au sport du diabetique traite par insuline. Diabète et Métabolisme, 14 (2), 127-35. |
Paolisso, G., Sgambato, S., Giugliano, D., Torella, R., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1988). Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 31 (12), 910-5. doi:10.1007/BF00265376 |
Paolisso, G., Sgambato, S., Torella, R., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1988). Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism, 66 (6), 1220-6. doi:10.1210/jcem-66-6-1220 |
Paquot, N., Scheen, A., Franchimont, P., & Lefebvre, P. (1988). The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabète et Métabolisme, 14 (1), 31-6. |
Scheen, A., Castillo, M., & Lefebvre, P. (1988). Insulin sensitivity in anorexia nervosa: a mirror image of obesity? Diabetes/Metabolism Reviews, 4 (7), 681-90. doi:10.1002/dmr.5610040705 |
Scheen, A., Paquot, N., & Lefebvre, P. (1988). Perspectives concernant les voies d'administration inhabituelles de l'insuline. Les voies orale, rectale et nasale. Annales d'Endocrinologie, 49 (4-5), 386-90. |
PAQUOT, N., Henrivaux, Scheen, A., JANDRAIN, B., & LEFEBVRE, P. (03 April 1987). Changes in plasma and erythrocyte magnesium concentrations during protein- sparing modified fast (PSMF) in obese subjects: comparison Alburone versus Nutroclin VLC [Poster presentation]. Symposium "Magnesium in daily practice: clinical and therapeutical implications", Anvers, Belgium. |
PAQUOT, N., SCHEEN, A., & Lefèbvre, P. (April 1987). Effets métaboliques et hormonaux d'un spray nasal d'insuline chez le sujet normal. Acta Clinica Belgica, 42 (5). |
Castillo, M., Scheen, A., Paolisso, G., & Lefebvre, P. (1987). The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. Acta Endocrinologica, 116 (3), 364-72. doi:10.1530/acta.0.1160364 |
Paolisso, G., Giugliano, D., Scheen, A., Franchimont, P., D'Onofrio, F., & Lefebvre, P. (1987). Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. Acta Endocrinologica, 115 (2), 161-9. doi:10.1530/acta.0.1150161 |
Paolisso, G., Scheen, A., Luyckx, A. S., & Lefebvre, P. (1987). Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. American Journal of Physiology, 252 (1 Pt 1), 1-7. doi:10.1152/ajpendo.1987.252.1.e1 |
Paolisso, G., Sgambato, S., Passariello, N., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1987). Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels. Diabetes, 36 (5), 566-70. doi:10.2337/diab.36.5.566 |
Scheen, A., Henrivaux, P., Jandrain, B., & Lefebvre, P. (1987). U-100 insulin gives some protection against metabolic deterioration due to CSII interruption. Diabetes Care, 10 (6), 707-11. doi:10.2337/diacare.10.6.707 |
Scheen, A., Henrivaux, P., Jandrain, B., Paolisso, G., & Lefebvre, P. (1987). Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII. Diabetes Care, 10 (5), 567-72. doi:10.2337/diacare.10.5.567 |
Scheen, A., Jaminet, C., Luyckx, A. S., & Lefebvre, P. (1987). Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 25 (2), 70-6. |
Lefebvre, P., Luyckx, A., Krzentowski, G., Jandrain, B., Pirnay, F., Crielaard, J.-M., Mosora, F., Lacroix, M., & Pallikarakis, N. (1986). Utilisation d'une charge orale de glucose donnée avant, pendant ou après un exercice musculaire prolongé. Cahiers de Nutrition et de Diététique, XXI, 129-131. |
Luyckx, A. S., Daubresse, J. C., Jaminet, C., Scheen, A., & Lefebvre, P. (1986). Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin. Acta Diabetologica Latina, 23 (2), 101-6. doi:10.1007/BF02624669 |
Paolisso, G., Scheen, A., Verdin, E., Luyckx, A. S., & Lefebvre, P. (1986). Insulin oscillations per se do not affect glucose turnover parameters in normal man. Journal of Clinical Endocrinology and Metabolism, 63 (2), 520-5. doi:10.1210/jcem-63-2-520 |
Paolisso, G., Sgambato, S., Passariello, N., Giugliano, D., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1986). Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia, 29 (9), 644-7. doi:10.1007/BF00869264 |
Castillo, M., Scheen, A., Lefebvre, P., & Luyckx, A. S. (1985). Insulin-stimulated glucose disposal is not increased in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 60 (2), 311-4. doi:10.1210/jcem-60-2-311 |
Scheen, A., Castillo, M., Jandrain, B., Krzentowski, G., Henrivaux, P., Luyckx, A. S., & Lefebvre, P. (1984). Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care, 7 (4), 338-42. doi:10.2337/diacare.7.4.338 |
Scheen, A., Lefebvre, P., & Luyckx, A. S. (1984). Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. European Journal of Clinical Pharmacology, 26 (4), 471-4. doi:10.1007/BF00542143 |
Castillo, M. J., Scheen, A., Luyckx, A. S., & Lefebvre, P. (1983). Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter. Diabetologia, 25 (2), 120-2. doi:10.1007/BF00250899 |
Krzentowski, G., Scheen, A., Castillo, M., Luyckx, A. S., & Lefebvre, P. (1983). A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia, 24 (5), 314-8. doi:10.1007/BF00251815 |
Scheen, A., Luyckx, A. S., Fossion, A., & Lefebvre, P. (1983). Effect of protein-supplemented fasting on the fuel-hormone response to prolonged exercise in obese subjects. International Journal of Obesity, 7 (4), 327-37. |
Scheen, A., Pirnay, F., Luyckx, A. S., & Lefebvre, P. (1983). Metabolic adaptation to prolonged exercise in severely obese subjects. International Journal of Obesity, 7 (3), 221-9. |
Pirnay, F., Krzentowski, G., Crielaard, J.-M., Pallikarakis, N., Lacroix, M., Mosora, F., Luyckx, A., & Lefèbvre, P. (1982). Fate of exogneous glucose metabolism during exercise of different intensities in humans. Journal of Applied Physiology, 53, 1620-1624. |
Scheen, A., Luyckx, A. S., Scheen, M., & Lefebvre, P. (1982). Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects. International Journal of Obesity, 6 (2), 165-74. |
Luyckx, A. S., Guerten, D., Scheen, A., Delporte, J.-P., Lefebvre, P., & Jaminet, F. (1981). Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects. Acta Diabetologica Latina, 18 (3), 259-66. doi:10.1007/BF02047898 |
Pirnay, F., Krzentowski, G., Crielaard, J.-M., Pallikarakis, N., Lacroix, M., Mosora, F., Luyckx, A., & Lefèbvre, P. (1981). Oxidation and orally administrated 'naturally labeled 13C-glucose' during prolonged muscular exercise : 100g versus 4 x 250g. In J. Poortmans, Biochemistry of exercise IV-A : 4th International Symposium of Biochemistry on Exercise, June 19-22, 1979, Bruxelles (pp. 196-207). Baltimore, United States - Maryland: University Park Press. |